PCRX
Pacira BioSciences, Inc. · Healthcare · Market cap $1.1B
Insiders sold $443K net in the last 90 days ·3 sellers, 0 buyers· 3 of 3 sales under Rule 10b5-1 plans· latest Form 4 filed Aug 18, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.6M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Aug 18, 2026
SLONIN JONATHAN
Pacira BioSciences, Inc. (PCRX) has 37 SEC Form 4 filings (50 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 18, 2026.
Inside the rolling window, 6 insiders at Pacira BioSciences, Inc. reported no open-market purchases and 17 open-market sales totaling $2.6M. The most active filer is Chief Financial Officer Cross Shawn with 7 filings. Insiders have net sold $1.2M over the trailing 6 months. The most recent open-market filing is a sale of 3,040 shares by Chief Medical Officer SLONIN JONATHAN, dated Aug 17, 2026, worth $71K.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Frank D. Lee
- Employees:788
- HQ:Tampa, FL, US
- IPO:2011-02-03
| Source | |||||||
|---|---|---|---|---|---|---|---|
SLONIN JONATHANFirst in 5 months | Chief Medical Officer | Sale | 3,040 | $71K | Aug 18 | +9.8% | SEC ↗ |
RIKER LAURENFirst in 4 months | Senior Vice President, Finance | Sale | 6,115 | $144K | Jun 13 | +15.9% | SEC ↗ |
WILLIAMS KRISTENFirst in 4 months | Chief Administrative Officer | Sale | 10,259 | $228K | Jun 5 | +15.8% | SEC ↗ |
| Chief Financial Officer | Sale | 12,941 | $326K | Apr 25 | +3.1% | SEC ↗ | |
Cross ShawnFirst in 4 months | Chief Financial Officer | Sale | 7,714 | $194K | Apr 22 | +5.9% | SEC ↗ |
Cross ShawnFirst in 4 months | Chief Financial Officer | Sale | 2,845 | $71K | Apr 22 | +5.9% | SEC ↗ |
Cross ShawnFirst in 4 months | Chief Financial Officer | Sale | 1,500 | $38K | Apr 22 | +5.9% | SEC ↗ |
SLONIN JONATHANFirst in 4 months | Chief Medical Officer | Sale | 3,261 | $74K | Mar 19 | +16.7% | SEC ↗ |
Froimson MarkFirst filing | Director | Sale | 500 | $11K | Mar 19 | +16.7% | SEC ↗ |
| Senior Vice President, Finance | Sale | 4,000 | $83K | Feb 3 | +25.4% | SEC ↗ | |
WILLIAMS KRISTENFirst filing | Chief Administrative Officer | Sale | 13,137 | $270K | Feb 3 | — | SEC ↗ |
RIKER LAURENFirst filing | Senior Vice President, Finance | Sale | 1,416 | $34K | Jan 6 | — | SEC ↗ |
| Chief Financial Officer | Sale | 15,896 | $398K | Dec 11 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 9,104 | $229K | Dec 11 | — | SEC ↗ | |
SLONIN JONATHANFirst filing | Chief Medical Officer | Sale | 3,960 | $95K | Nov 19 | — | SEC ↗ |
Cross ShawnFirst filing | Chief Financial Officer | Sale | 12,060 | $266K | Nov 13 | — | SEC ↗ |
Ceesay AbrahamFirst filing | Director | Sale | 2,354 | $64K | Sep 8 | — | SEC ↗ |
Congress trading PCRX 2 all-time
- DRep. Tom MalinowskiPurchase$1,001 - $15,0002021-05-06
- DRep. Tom MalinowskiPurchase$1,001 - $15,0002021-04-20
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does PCRX have?
Pacira BioSciences, Inc. (PCRX) has 37 SEC Form 4 filings (50 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Aug 18, 2026.
When was the most recent SEC Form 4 filing for PCRX?
The most recent Form 4 filing for PCRX on Tracefour is dated Aug 18, 2026.
Who is the most active insider at PCRX?
The most active SEC Form 4 filer at PCRX in the rolling window is Chief Financial Officer Cross Shawn, with 7 filings.
What is the net insider flow at PCRX over the last 6 months?
Over the trailing 180 days, insiders at PCRX have net sold $1.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at PCRX in the current window?
Inside the rolling window, insiders at PCRX bought $0 and sold $2.6M based on SEC Form 4 filings.
Can I get alerts for PCRX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Pacira BioSciences, Inc. (PCRX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Pacira BioSciences, Inc. is in the Healthcare sector.